Page last updated: 2024-09-02

n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide and Adenocarcinoma

n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide has been researched along with Adenocarcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baguley, BC; Marshall, E; Zhuang, L1
Baguley, BC; Finlay, GJ; Haldane, A; Holdaway, KM1

Other Studies

2 other study(ies) available for n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide and Adenocarcinoma

ArticleYear
Experimental solid tumour activity of N-[2-(dimethylamino)ethyl]-acridine-4-carboxamide.
    Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:3

    Topics: Acridines; Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Cell Line; Colonic Neoplasms; Humans; Intercalating Agents; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Regression Analysis; Time Factors; Transplantation, Heterologous

1995
Cytokinetic differences in the action of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide as compared with that of amsacrine and doxorubicin.
    Cancer chemotherapy and pharmacology, 1993, Volume: 32, Issue:6

    Topics: Acridines; Adenocarcinoma; Amsacrine; Antineoplastic Agents; Cell Cycle; DNA, Neoplasm; Doxorubicin; Flow Cytometry; Lung Neoplasms; Tumor Cells, Cultured

1993